Correlation Between Richmond Vanadium and Aroa Biosurgery

Can any of the company-specific risk be diversified away by investing in both Richmond Vanadium and Aroa Biosurgery at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Richmond Vanadium and Aroa Biosurgery into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Richmond Vanadium Technology and Aroa Biosurgery, you can compare the effects of market volatilities on Richmond Vanadium and Aroa Biosurgery and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Richmond Vanadium with a short position of Aroa Biosurgery. Check out your portfolio center. Please also check ongoing floating volatility patterns of Richmond Vanadium and Aroa Biosurgery.

Diversification Opportunities for Richmond Vanadium and Aroa Biosurgery

0.61

Correlation Coefficient

Richmond Vanadium  Aroa Biosurgery

Poor diversification

The 3 months correlation between Richmond and Aroa is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Richmond Vanadium Technology and Aroa Biosurgery in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aroa Biosurgery and Richmond Vanadium is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Richmond Vanadium Technology are associated (or correlated) with Aroa Biosurgery. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aroa Biosurgery has no effect on the direction of Richmond Vanadium i.e., Richmond Vanadium and Aroa Biosurgery go up and down completely randomly.

Pair Corralation between Richmond Vanadium and Aroa Biosurgery

Assuming the 90 days trading horizon Richmond Vanadium Technology is expected to generate 1.84 times more return on investment than Aroa Biosurgery. However, Richmond Vanadium is 1.84 times more volatile than Aroa Biosurgery. It trades about -0.04 of its potential returns per unit of risk. Aroa Biosurgery is currently generating about -0.11 per unit of risk. If you would invest  22.00  in Richmond Vanadium Technology on December 21, 2024 and sell it today you would lose (7.00) from holding Richmond Vanadium Technology or give up 31.82% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Richmond Vanadium Technology  vs.  Aroa Biosurgery

Richmond Vanadium

Risk-Adjusted Performance

Very Weak

Over the last 90 days Richmond Vanadium Technology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Aroa Biosurgery

Risk-Adjusted Performance

Very Weak

Over the last 90 days Aroa Biosurgery has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Richmond Vanadium and Aroa Biosurgery

The main advantage of trading using opposite Richmond Vanadium and Aroa Biosurgery positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Richmond Vanadium position performs unexpectedly, Aroa Biosurgery can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aroa Biosurgery will offset losses from the drop in Aroa Biosurgery's long position.

The idea behind Richmond Vanadium Technology and Aroa Biosurgery pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.